openPR Logo
Press release

Pharmacogenomics Market Poised for Boom Featuring Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and Pharmigene

08-18-2025 03:33 PM CET | Health & Medicine

Press release from: Coherent Market Insights Pvt. Ltd.

Pharmacogenomics Market

Pharmacogenomics Market

The "Pharmacogenomics Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Pharmacogenomics industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. This study does a thorough examination of the market and offers insights based on an industry SWOT analysis. The report on the Pharmacogenomics Market provides access to critical information such as market growth drivers, market growth restraints, current market trends, the market's economic and financial structure, and other key market details.

This report is a detailed and comprehensive analysis for Global Pharmacogenomics Market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.

➤ Request a Sample of the Pharmacogenomics Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/1053

➤ Scope of Pharmacogenomics Market Report:

The Pharmacogenomics Market Research presents a detailed analysis of trends, drivers, and challenges within the industry. It includes thorough insights into market segmentation by product type, application, and geography. The report highlights major players and their competitive strategies, as well as emerging opportunities for growth. It also investigates consumer behavior and preferences that affect market dynamics. Forecasts for market size and growth potential in the upcoming years are included, backed by quantitative data. It also addresses regulatory factors and technological advancements influencing the market, making this report a valuable resource for stakeholders looking to make informed business decisions.

➤ Key Players Highlighted in This Report:

• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Pharmigene
• Abbott
• Agilent Technologies Inc.
• QIAGEN
• GE HealthCare
• Empire Genomics Inc.
• Bio-Rad Laboratories
• Inc.
• Oxford Nanopore Technologies plc.
• PerkinElmer Inc.
• Myriad Genetics Inc.
• IlluminaInc.
• MacrogenInc.
• BGI Genomics
• Eurofins Scientific
• MapMyGenome
• and Invitae Corporation

By Product Type:
• Emergency Air Transport
• Medical Air Transport
• Hospital Transfer Services
By Application:
• Emergency Medical Services
• Inter-facility Transport
• Organ Transport
By End User:
• Hospitals
• Emergency Services
• Government Agencies
By Region:
• North America
• Europe
• Asia Pacific
• Rest of World

➤ Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1053

➤ Research Methodology:

The report has its roots definitely set in thorough strategies provided by proficient data analysts. The research methodology involves the collection of information by analysts only to have them studied and filtered thoroughly in an attempt to provide significant predictions about the market over the review period. The research process further includes interviews with leading market influencers, which makes the primary research relevant and practical. The secondary method gives a direct peek into the demand and supply connection. The market methodologies adopted in the report offer precise data analysis and provide a tour of the entire market. Both primary and secondary approaches to data collection have been used. In addition to these, publicly available sources such as annual reports, and white papers have been used by data analysts for an insightful understanding of the market.

➤ Regional Outlook:

The insights and outlooks on Pharmacogenomics Market drivers, trends, and influencing factors are also included in the study. The Pharmacogenomics Market report provides estimations and the market sizing and prospects of various regions. To this end, the study makes in-depth segmentation of the following key regions:
• North America (U.S. and Canada)
• Latin America (Mexico, Brazil, Peru, Chile, and others)
• Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
• Eastern Europe (Poland and Russia)
• Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
• The Middle East and Africa (GCC, Southern Africa, and North Africa)
The major points covered in the table of contents:

➤ Overview: This part provides a summary of the report, as well as a broad overview of the global Pharmacogenomics Market, to offer an understanding of the nature and contents of the research study.

➤ Market Analysis: The research forecasts the market share of key segments of the Pharmacogenomics Market with accuracy and reliability. This study may be used by industry participants to make strategic investments in key growth areas of the Pharmacogenomics Market.

➤ Analysis of Leading Players Strategies: This report can be used by market participants to acquire a competitive advantage over their rivals in the Pharmacogenomics Market.

➤ Regional Growth Analysis: The report covers all of the key areas and countries. The regional analysis will assist market players in tapping into untapped regional markets, developing unique regional strategies, and comparing the growth of all regional markets.

➤ Market Forecasts: Report purchasers will get access to precise and validated estimations of the entire market size in terms of both value and volume. The study also includes estimates for the Pharmacogenomics Market in terms of consumption, production, sales, and other factors.

➤ Having our reviews and subscribing to our report will help you solve the subsequent issues:

• Uncertainty about the future: Our research and insights help our customers predict the upcoming revenue pockets and growth areas. This will guide customers to invest their resources.
• Understanding market sentiments: It is very important to have a fair understanding of market sentiment for your strategy. Our insights will help you see every single eye on market sentiment.
• Understanding the most reliable investment center: Our research evaluates investment centers in the market, taking into account future demand, profits, and returns. Clients can focus on the most prestigious investment centers through market research.
• Evaluating potential business partners: Our research and insights help our clients in identifying compatible business partners.

➤ Reasons to buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying Top Manufacturers.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

➤ Get Discount on Pharmacogenomics Analysis Report https://www.coherentmarketinsights.com/insight/buy-now/1053

➤ FAQ's

1. Which are the key dominating players in the market?

2. What are the key business strategies chosen by the leading player to sustain in the Global Pharmacogenomics Market?

3. What are the primary reasons behind the faster market growth rate?

4. Which are the dominating growth factors likely to propel the regional development of the Pharmacogenomics industry?

5. What is the expected growth rate of the Global Pharmacogenomics Market during the forecast period?

Author of this marketing PR:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.


About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Contact Us:

Mr. Shah
Coherent Market Insights
533 Airport Boulevard,
Suite 400, Burlingame,
CA 94010, United States
US: + 12524771362
UK: +442039578553
AUS: +61-8-7924-7805
India: +91-848-285-0837

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market Poised for Boom Featuring Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, and Pharmigene here

News-ID: 4148241 • Views:

More Releases from Coherent Market Insights Pvt. Ltd.

Vacuum Blood Collection Tube Market Is Booming So Rapidly By 2032 | Becton, Dickinson and Company, Terumo Corporation
Vacuum Blood Collection Tube Market Is Booming So Rapidly By 2032 | Becton, Dick …
Coherent Market Insights has released a report titled "Vacuum Blood Collection Tube Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins. This comprehensive
Absorbable Bone Fixation Device Market Generated Opportunities, Future Scope By 2032 | B. Braun Melsungen AG, Medtronic plc, Stryker Corporation
Absorbable Bone Fixation Device Market Generated Opportunities, Future Scope By …
Overview The "Absorbable Bone Fixation Device Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Absorbable Bone Fixation Device industry, as well as predicted future growth, technological advancements,
Medical Pressure Relief Devices Market Set to Witness Significant Growth by 2025-2032 | Hill-Rom Holdings, Inc., Invacare Corporation
Medical Pressure Relief Devices Market Set to Witness Significant Growth by 2025 …
The latest Report titled "Medical Pressure Relief Devices Market 2025" by Coherent Market Insights offers valuable insights into the global and regional market outlook from 2025 to 2032. This detailed study explores changing market trends, investment hotspots, competitive landscape, regional developments, and key segments. It also examines the main factors driving or slowing market growth and highlights strategies and opportunities to help businesses stay ahead. This report is designed to support
Laser Therapy Devices Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Erchonia Corporation, BTL Industries, BioFlex Laser Therapy
Laser Therapy Devices Market Exclusive Report with Detailed Study Analysis By 20 …
Overview The "Laser Therapy Devices Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Laser Therapy Devices industry, as well as predicted future growth, technological advancements, investment prospects,

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Pharmacogenomics Market are: • F. Hoffmann-la Roche Ltd • Abbott • Oxford Nanopore Technologies • Thermo Fisher Scientific Inc. • Illumina, Inc. • QIAGEN • Agilent Technologies, Inc. • Myriad Genetics, Inc. • Admera Health Contact Us: If you have any queries about
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain